GL1X · GenesisL1 explorer

MolNFT v1 · #10326 · protein

A sialic acid derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies

1INY · Influenza a subtype N9 neuraminidase: “A sialic acid derived phosphonate analog inhibits different strains of influenza virus neuraminidase with…”. X-ray diffraction, 5 ligands (EQP, NAG, MAN), 2 pockets (best druggability 0.65).…

PDB
1INY
Type
protein
Length
388 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Influenza a subtype N9 neuraminidase
EC
3.2.1.18
UniProt
P03472
Ligands
EQP, NAG, MAN, BMA, CA
Pockets
2 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInfluenza a subtype N9 neuraminidase (EC 3.2.1.18)protein3884% helix, 44% strandP03472

Ligands and binding sites

  • EQP · (1R)-4-acetamido-1,5-anhydro-2,4-dideoxy-1-phosphono-D-glycero-D-galacto-octitol · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 4 copies
  • BMA · beta-D-mannopyranose · sugar
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13410.650.8042EQP
2510.360.8016empty

Modifications

Observed in the structure: 9 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 1INY · A sialic acid derived phosphonate analog inhibits different strains of influenza virus… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.